Right Mini-Thoracotomy versus Standard Sternotomy for Surgical Excision of Atrial Myxomas

Document Type : Original Article

Author

Thoracic Surgeon, Cardiothoracic Surgery Department, Faculty of Medicine, Minia University, Egypt. Madinah Cardiac Center, King Fahad Hospital, Madinah, KSA.

Abstract

Introduction: Atrial myxomas are rare benign tumors; causing obstructive or embolic complications, or even death, depending on their site and size. Therefore, once diagnosed, it should be surgically resected. Atrial myxomas are present about 75% in left atrium (LA) and about 15% in right atrium (RA). Early diagnosis is a challenge because of nonspecific manifestations, and sometimes is asymptomatic and may be discovered accidentally during transthoracic echography (TTE).Minimally invasive cardiac surgery (MICS) has benefits over sternotomy include cosmetically, less pain, and shorter total hospital stay.
Materials and Methods:Between January 2011 to December 2020, (50) patients [30 Sternotomy, 20 MICS] underwent surgery for isolated resection of cardiac myxoma. We reported outcomes; cardiopulmonary bypass (CPB) time, aortic cross-clamp (ACC) time, conversion to median sternotomy
(ST), total hospital stay, complications (stroke, renal failure, respiratory failure, reoperation, and infection), pain, patient¢s satisfaction, recurrence and survival. Follow-up time was from 6-months to 3-years.
 Results: There is no significant difference in CPB or cross-clamp time between groups. No minimal invasive (MI) cases required conversion to a median ST. Total hospital stay is shorter in the MI group by 2.2 days (p-value = 0.045).  No differences present in morbidity or mortality between two groups.
Conclusions: Surgical resection of atrial myxoma resection by minimal invasive approach is safe, feasible, and favored over sternotomy





 

Keywords


1.             Numaguchi R, Hashimoto M, Koshima R, Mitsube K. Surgical treatment of a giant right atrial myxoma. Surgical Case Reports. 2020;6(1):1-3.
2.             Omar M, Sindby JE, Blaskauskaite A, Zaremba T, Jensen SE. Atrial Myxoma with a dual coronary artery supply. International Journal of Clinical Medicine. 2017;8(06):368.
3.             Jiang X, Wang Y, Mohl W, Si Z. Right Ventricular Myxoma Causing Right Ventricular Outflow Tract Obstruction: A Case Report. Open Journal of Clinical Diagnostics. 2015;5(03):121.
4.             Korkmaz AA, Tamtekin B, Onan B, Demir AS, Guden M, Uckurt Y. Combination of right atrial and left ventricular myxoma. The Annals of thoracic surgery. 2010;89(5):e33-e5.
5.             Selkane C, Amahzoune B, Chavanis N, Raisky O, Robin J, Ninet J, et al. Changing management of cardiac myxoma based on a series of 40 cases with long-term follow-up. The Annals of thoracic surgery. 2003;76(6):1935-8.
6.             Yu S, Xu X, Zhao B, Jin Z, Gao Z, Wang Y, et al. Totally thoracoscopic surgical resection of cardiac myxoma in 12 patients. The Annals of thoracic surgery. 2010;90(2):674-6.
7.             Hur DJ, Prescher LM, Meadows JL, Pfau SE, Homer RJ, Tellides G, et al. Multimodality imaging involving magnetic resonance facilitates giant symptomatic myxoma resection. The Annals of thoracic surgery. 2019;107(1):e15-e7.
8.             Sawaki S, Ito T, Maekawa A, Hoshino S, Hayashi Y, Yanagisawa J, et al. Outcomes of video-assisted minimally invasive approach through right mini-thoracotomy for resection of benign cardiac masses; compared with median sternotomy. General thoracic and cardiovascular surgery. 2015;63(3):142-6.
9.             Iribarne A, Easterwood R, Russo MJ, Yang J, Cheema FH, Smith CR, et al. Long-term outcomes with a minimally invasive approach for resection of cardiac masses. The Annals of thoracic surgery. 2010;90(4):1251-5.
10.          Pineda AM, Santana O, Zamora C, Benjo AM, Lamas GA, Lamelas J. Outcomes of a minimally invasive approach compared with median sternotomy for the excision of benign cardiac masses. The Annals of thoracic surgery. 2011;91(5):1440-4.
11.          Mubarak Y. Excision of Atrial Myxomas is progressing from Median Sternotomy to Mini-Thoracotomy. Authorea Preprints. 2020.
12.          Thyagarajan B, Priyadarshini Kumar M, Patel S, Agrawal A. Extracardiac manifestations of atrial myxomas. J Saudi Heart Assoc 2017; 29: 37-43.
13.          Holbert J, Rogers B, Bresee S. Dueling myxomas: a rare finding. CASE: Cardiovascular Imaging Case Reports. 2019;3(4):167.
14.          Luo C, Zhu J, Bao C, Ding F, Mei J. Minimally invasive and conventional surgical treatment of primary benign cardiac tumors. Journal of cardiothoracic surgery. 2019;14(1):1-7.
15.          Seaburg LA, Wang AT, West CP, Reed DA, Halvorsen AJ, Engstler G, et al. Associations between resident physicians’ publications and clinical performance during residency training. BMC medical education. 2016;16(1):1-6.
16.          Kong X, Zhou M, Tu X, Wang J, Yao Y. Multiple recurrent cardiac myxomas with protein kinase a regulatory subunit 1α gene mutation. The Annals of thoracic surgery. 2019;107(2):e83-e5.
17.          Beigoli S, Sharifi Rad A, Askari A, Assaran Darban R, Chamani J. Isothermal titration calorimetry and stopped flow circular dichroism investigations of the interaction between lomefloxacin and human serum albumin in the presence of amino acids. Journal of Biomolecular Structure & Dynamics. 2019;37(9):2265-2282.
18.          Chamani J, Moosavi-Movahedi AA, Saboury AA, Gharanfoli M, Hakimelahi GH. Calorimetric indication of the molten globule-like state of cytochrome c induced by n-alkyl sulfates at low concentrations. The Journal of Chemical Thermodynamics. 2003;35(2):199-207.
19.          Beigoli S, Hekmat A, Farzanegan F, Darroudi M. Green synthesis of amorphous calcium phosphate nanopowders using Aloe Vera plant extract and assessment of their cytotoxicity and antimicrobial activities. Journal of Sol-Gel Science and Technology. 2021:1-9.
20.          El-Fiky MM, El-Sayegh T, El-Beishry AS, Abdul Aziz M, Aboul Enein H, Waheid S, et al. Limited right anterolateral thoracotomy for mitral valve surgery. European journal of cardio-thoracic surgery. 2000;17(6):710-3.